Literature DB >> 2837402

Production of immunoreactive insulin-like growth factor I and response to exogenous IGF-I in small cell lung cancer cell lines.

G Jaques1, M Rotsch, C Wegmann, U Worsch, M Maasberg, K Havemann.   

Abstract

Small cell lung cancer (SCLC) cell lines were examined for the presence of insulin-like growth factor I-related protein (IGF-I) in cell pellets and culture media. IGF-I immunoreactivity was detected in 11/14 pellets, ranging from 12 to 76 mIU/mg soluble protein. The IGF-I levels in the cell pellets showed a correlation to the corresponding culture media. IGF-I binding sites were found in all tested cell lines. The maximum binding (Bmax) ranged from 131 to 1230 fmol/mg protein and the dissociation constant (KD) from 0.89 to 5.21 nM. The incorporation of [3H]thymidine in the presence of recombinant human IGF-I resulted in a clearly increased DNA synthesis in two of seven cell lines. Thus, IGF-I may be an important growth factor in SCLC.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2837402     DOI: 10.1016/0014-4827(88)90335-7

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  12 in total

Review 1.  New perspectives in lung cancer. 2. Growth factors and lung cancer.

Authors:  P J Woll
Journal:  Thorax       Date:  1991-12       Impact factor: 9.139

2.  Phenotype alteration in colon carcinoma cells: effect of in vivo passage?

Authors:  M A Maley; A K House; D J Jenkyn; G Sterrett
Journal:  In Vitro Cell Dev Biol       Date:  1991-05

3.  Overexpression of the human insulinlike growth factor I receptor promotes ligand-dependent neoplastic transformation.

Authors:  M Kaleko; W J Rutter; A D Miller
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

Review 4.  Insulin-like growth factors in central nervous system tumors.

Authors:  R P Glick; T Lichtor; T G Unterman
Journal:  J Neurooncol       Date:  1997-12       Impact factor: 4.130

Review 5.  Novel therapies in small cell lung cancer.

Authors:  Hirva Mamdani; Raghava Induru; Shadia I Jalal
Journal:  Transl Lung Cancer Res       Date:  2015-10

Review 6.  Acromegaly: re-thinking the cancer risk.

Authors:  Siobhan Loeper; Shereen Ezzat
Journal:  Rev Endocr Metab Disord       Date:  2008-03       Impact factor: 6.514

7.  Expression of insulin-like growth factor receptors I and II in normal human lung and in lung cancer.

Authors:  U Kaiser; C Schardt; D Brandscheidt; E Wollmer; K Havemann
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

8.  Acromegaly and anaplastic astrocytoma: coincidence or pathophysiological relation?

Authors:  Alberto Fernandez; Niki Karavitaki; Olaf Ansorge; Violet Fazal-Sanderson; John A H Wass
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

9.  Enhancement of transforming potential of human insulinlike growth factor 1 receptor by N-terminal truncation and fusion to avian sarcoma virus UR2 gag sequence.

Authors:  D Liu; W J Rutter; L H Wang
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

10.  Pulmonary epidermoid carcinoma in a patient with acromegaly: a rare entity.

Authors:  Siham El Aziz; Asma Chadli; Atika Obbiba; Hassan El Ghomari; Ahmed Farouqi
Journal:  Pan Afr Med J       Date:  2012-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.